“Psychedelics crosscut so many interesting domains. They've been used for time immemorial by indigenous cultures. In our own Western cultural history, they really exploded on the scene in the 1960s, and were associated with radical changes to society.”

A powerful psychedelic long used in African rituals shows surprising promise for treating traumatic brain injury and PTSD.

MAPS founder Rick Doblin speaks to Big Think about the FDA’s rejection of MDMA therapy and the future of psychedelic treatments.

“Neurotech is not just about the brain,” says Synchron CTO Riki Banerjee, explaining how their tech can help with paralysis, brain diseases, and beyond.

For a substantial part of human history, people thought smoking tobacco was perfectly healthy. Native American tribes, who introduced the tobacco plant to Europeans and — by extension, the rest […]

"By 2040, we hope to see a number of new drugs that have been designed with AI reaching patients."

Fixing chronic pain in the body may sometimes require a treatment focused on the brain.

The hangover "cures" on the market don't work. A new hydrogel does.

GLP-1 agonists may be able to treat addiction, prevent Alzheimer’s, and more.

A new family of drugs is changing the way scientists are thinking about obesity.

Poor research can be worse than no research at all.

Vaccines targeting some of our deadliest cancers are showing promise in early trials.

More than 90% of ticks that bit treated volunteers were dead within 24 hours.

The sober reality behind the effectiveness of two new drugs touted as Alzheimer's breakthroughs: lecanemab and donanemab.

They call it “Judo T-cell therapy,” and it’s 100 times more potent than regular CAR-T cells.

The brain-computer interface will be tested in a six-year trial in patients with quadriplegia.

Placebo treatments don't always need to be given deceptively to have positive effects.

Embedded in a cell phone or in accessories such as rings, bracelets or watches, the novel tools aim to make it easier to manage hypertension. But they must still pass several tests before hitting the clinic.

There is currently no easy way to treat high Lp(a). A single shot could change that.

The first human trial of base editing delivered strong results along with some safety concerns.

A cure may be on the horizon.

EBT-101 is not the only candidate for an HIV cure. Stem cell transplants, medications, and other CRISPR therapies are being researched.

Don't bet your money on it.

What a long strange trip it's been.

Capsaicin is already used to treat nerve pain. Early research hints it could do more.

The benefits of the psychedelic seem to last long after the trip wears off.

The milestone puts us one step closer to ending the organ shortage.

Since the 1980s, engineered monoclonal antibodies have been knocking out invading germs. Sperm may be next.

Long thought a pipe dream, scientists have discovered a drug that mimics the effects of exercise.

“I think it has a real chance to reverse motor symptoms, essentially replacing a missing part.”